TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Biosupply AS
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,338
|
1,393
|
1,301 |
| Financial expenses |
6
|
6
|
4 |
| Earnings before taxes |
189
|
112
|
-60 |
| Total assets |
768
|
577
|
544 |
| Current assets |
514
|
352
|
302 |
| Current liabilities |
101
|
94
|
116 |
| Equity capital |
538
|
411
|
326 |
| - share capital |
253
|
267
|
285 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
70.1%
|
71.2%
|
59.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
14.1%
|
8.0%
|
-4.6% |
| Return on assets (ROA) |
25.4%
|
20.5%
|
-10.3% |
| Current ratio |
508.9%
|
374.5%
|
260.3% |
| Return on equity (ROE) |
35.1%
|
27.3%
|
-18.4% |
| Change turnover |
16
|
175
|
204 |
| Change turnover % |
1%
|
14%
|
19% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.